Inventor · disambiguated record
Lars Zender
Also filed as: ZENDER LARS
8 granted patents·13 pending applications·33 citations·filing 2006–2023
81Inventor score
Files withZENDER LARS6COLD SPRING HARBOR LAB3DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS3HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH2LOWE SCOTT W2
Top patents by PatentIndex Score
21 records- 0188US9186381B2Medicament for liver regeneration and for treatment of liver failureZENDER LARS·Filed 2012·Granted Nov 17, 2015·25 cites·3 claims
- 0277US2024024349A1Treatments of non-alcoholic steatohepatitis (nash)DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2023·Application pending·0 cites
- 0375US10188682B2Medicament for liver regeneration and for treatment of liver failureHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2015·Granted Jan 29, 2019·2 cites·4 claims
- 0473US8137907B2Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereofZENDER LARS·Filed 2008·Granted Mar 20, 2012·6 cites·18 claims
- 0571US11806361B2Treatments of non-alcoholic steatohepatitis (NASH)DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2021·Granted Nov 7, 2023·0 cites·11 claims
- 0667US11975032B2Medicament for liver regeneration and for treatment of liver failureHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2018·Granted May 7, 2024·0 cites·8 claims
- 0763US11052102B2Treatments of non-alcoholic steatohepatitis (NASH)DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2017·Granted Jul 6, 2021·0 cites·8 claims
- 0863US2023348462A1Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitorsDEUTSCHES KREBSFORSCH·Filed 2023·Application pending·0 cites
- 0958US7794941B2Role of FGF-20 in cancer diagnosis and treatmentCOLD SPRING HARBOR LAB·Filed 2007·Granted Sep 14, 2010·0 cites·12 claims
- 1058US2025020650A1Method of predicting a patient's benefit from therapy with an immune checkpoint inhibitorUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2022·Application pending·0 cites
- 1155US2024101538A1Protein-protein interaction modulators of aurora kinase a and their use in the prevention and/or treatment of cancerUNIV EBERHARD KARLS TUEBINGEN·Filed 2021·Application pending·0 cites
- 1251US2010273660A1ONCOGENOMICS-BASED RNAi SCREEN AND USE THEREOF TO IDENTIFY NOVEL TUMOR SUPPRESSORSCOLD SPRING HARBOR LAB·Filed 2009·Application pending·0 cites
- 1350US2011035814A1Cooperating oncogenes in cancerCOLD SPRING HARBOR LAB·Filed 2007·Application pending·0 cites
- 1449US2010297010A1Tumor suppressor gene screening using rna interference libraries and method of treatmentBRIC ANKA·Filed 2008·Application pending·0 cites
- 1547US2009022685A1Orthotopic, controllable, and genetically tractable non-human animal model for cancerLOWE SCOTT W·Filed 2007·Application pending·0 cites
- 1643US2010310504A1Methods for treating fibrosis by modulating cellular senescenceLOWE SCOTT W·Filed 2008·Application pending·0 cites
- 1741US10441577B2Medicament for treatment of liver cancerZENDER LARS·Filed 2012·Granted Oct 15, 2019·0 cites·7 claims
- 1840US2019381198A1Radiolabeled beta-galactosidase substrate for pet imaging of senescenceUNIV TUEBINGEN MEDIZINISCHE FAKULTAET·Filed 2019·Application pending·0 cites
- 1939US2012251579A1Compositions for generating an antigen specific immune responseZENDER LARS·Filed 2010·Application pending·0 cites
- 2039US2020000787A1Medicament for treatment of liver cancerZENDER LARS·Filed 2019·Application pending·0 cites
- 2137US2006162000A1Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancerZENDER LARS·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Zender files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →